Status:
COMPLETED
Fibroblast Growth Factors 19 and 21 in Gestational Diabetes Mellitus
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) is the most common complication in pregnancy. Both mother and offspring have a significantly increased future risk for metabolic and cardiovascular disease as a con...
Detailed Description
First，30 pregnant women with GDM and 60 pregnant control women with normal glucose tolerance (NGT) matched for maternal and gestational age were enrolled in the study. All the subjects underwent antep...
Eligibility Criteria
Inclusion
- Women with singleton pregnancy;
- Regular antenatal examination from the first trimester;
- Give birth in the university hospital (The 1st affiliated hospital of Sun Yat-sen University)
Exclusion
- Younger than 18 years old;
- Older than 40 years old;
- Multiple pregnancy;
- Diagnosed DM before pregnancy;
- Complicated with other diseases such as hypertension, eclampsia, thyroid diseases, etc.;
- Taking any drug that affect glucose and lipid metabolism and insulin sensitivity.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01858597
Start Date
March 1 2013
End Date
March 1 2016
Last Update
May 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstetrics and Gynechology Department of the 1st affiliated hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510080